Expanded Access Programs, compassionate drug use, and Emergency Use Authorizations during the COVID-19 pandemic.
Rizk JG, Forthal DN, Kalantar-Zadeh K, Mehra MR, Lavie CJ, Rizk Y, et al. 2019 Novel Coronavirus, Wuhan, China: Interim Healthcare Infection Prevention and Control Recommendations for Patients Under Investigation for 2019 Novel Coronavirus. Decreasing Incidence of Chemosensory Changes by COVID-19 Variant. MaAccessed: December 1, 2021.Ĭoelho DH, Reiter ER, French E, Costanzo RM. Lost Sense of Smell May Be Peculiar Clue to Coronavirus Infection. Gastrointestinal implications in COVID-19. Zoghi G, Moosavy SH, Yavarian S, HasaniAzad M, Khorrami F, Sharegi Brojeni M, et al. Breathlessness and COVID-19: A Call for Research. Hentsch L, Cocetta S, Allali G, Santana I, Eason R, Adam E, et al. European Centre for Disease Prevention and Control. Shorter Incubation Period among COVID-19 Cases with the BA.1 Omicron Variant. Tanaka H, Ogata T, Shibata T, Nagai H, Takahashi Y, Kinoshita M, et al. Centers for Disease Control and Prevention. Underlying medical conditions associated with high risk for severe COVID-19: Information for healthcare providers. 2020 Dec 04.Ĭenters for Disease Control and Prevention. Summary of guidance for public health strategies to address high levels of community transmission of SARS-CoV-2 and related deaths, December 2020. Guidance for Implementing COVID-19 Prevention Strategies in the Context of Varying Community Transmission Levels and Vaccination Coverage. 2020 Mar 16 Accessed: December 1, 2021.Ĭhristie A, Brooks JT, Hicks LA, et al. Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand. ApAccessed: December 1, 2021.įerguson NM, Laydon D, Nedjati-Gilani G, Imai N, Ainslie K, Baguelin M, et al. Coronavirus Disease 2019 (COVID-19): Recommendations for Cloth Face Covers. Evidence for Limited Early Spread of COVID-19 Within the United States, January-February 2020.
FebruAccessed: December 1, 2021.ĬDC COVID-19 Response Team, Jorden MA, Rudman SL, et al. Severe acute respiratory syndrome-related coronavirus – The species and its viruses, a statement of the Coronavirus Study Group. WHO Director-General's remarks at the media briefing on 2019-nCoV on 11 February 2020. MaAccessed: December 1, 2021.Ĭoronavirus Updates: The Illness Now Has a Name: COVID-19. Declares Pandemic as Number of Infected Countries Grows. Declares Global Emergency as Wuhan Coronavirus Spreads. WHO Declares Public Health Emergency for Novel Coronavirus. On February 11, 2020, the Coronavirus Study Group of the International Committee on Taxonomy of Viruses issued a statement announcing an official designation for the novel virus: severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).ĬDC. Illness caused by SARS-CoV-2 was termed COVID-19 by the WHO, the acronym derived from "coronavirus disease 2019." The name was chosen to avoid stigmatizing the virus's origins in terms of populations, geography, or animal associations. On March 11, 2020, the WHO declared COVID-19 a global pandemic, its first such designation since declaring H1N1 influenza a pandemic in 2009. On January 30, 2020, the WHO declared the COVID-19 outbreak a global health emergency. It was initially reported to the WHO on December 31, 2019.
0 kommentar(er)
